Canada - français - Health Canada

juno pharmaceuticals corp. - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 2.5mg - bortézomib (bortézomib, ester boronique de mannitol) 2.5mg - antineoplastic agents

Canada - français - Health Canada

taro pharmaceuticals inc - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 3.5mg - bortézomib (bortézomib, ester boronique de mannitol) 3.5mg - antineoplastic agents

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Canada - français - Health Canada

janssen inc - daratumumab - solution - 1800mg - daratumumab 1800mg - antineoplastic agents

Canada - français - Health Canada

auro pharma inc - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 3.5mg - bortézomib (bortézomib, ester boronique de mannitol) 3.5mg - antineoplastic agents

Canada - français - Health Canada

gilead sciences canada inc - remdésivir - solution - 100mg - remdésivir 100mg - nucleosides and nucleotides

Canada - français - Health Canada

gilead sciences canada inc - remdésivir - poudre pour solution - 100mg - remdésivir 100mg - nucleosides and nucleotides

Canada - français - Health Canada

sandoz canada incorporated - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 3.5mg - bortézomib (bortézomib, ester boronique de mannitol) 3.5mg - antineoplastic agents

Canada - français - Health Canada

taro pharmaceuticals inc - bortézomib (bortézomib, ester boronique de mannitol) - poudre pour solution - 2.5mg - bortézomib (bortézomib, ester boronique de mannitol) 2.5mg - antineoplastic agents

Canada - français - Health Canada

hoffmann-la roche limited - casirivimab; imdévimab - solution - 1332mg; 1332mg - casirivimab 1332mg; imdévimab 1332mg - monoclonal antibodies